Alterity Therapeutics Limited

ATHE · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$12-$19-$14-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$3-$1
Stock-Based Comp.$1$1$1$2
Change in WC-$1$6-$4-$0
Other Non-Cash$0-$0-$6$0
Operating Cash Flow-$11-$13-$20-$12
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$8$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow-$8-$0-$0-$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$43$10$0$17
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$3-$1-$0-$1
Financing Cash Flow$40$9$0$16
Forex Effect-$0$0$1$3
Net Chg. in Cash$21-$3-$19$7
Supplemental Information
Beg. Cash$13$16$35$28
End Cash$33$13$16$35
Free Cash Flow-$11-$13-$20-$12
Alterity Therapeutics Limited (ATHE) Financial Statements & Key Stats | AlphaPilot